Katie Wright, Author at European Medical Journal - Page 42 of 45

3D Printing Boosts Confidence and Saves Time in Procedures

The use of 3D printing in healthcare significantly increases user confidence and saves time during medical procedures, according to a recent study.

PET Imaging Predicts Major Cardiac Events in Patients with Cardiac Sarcoidosis

Pet imaging may play a crucial role in identifying patients with cardiac sarcoidosis at higher risk of major adverse cardiac events, according to a new study.

Cotton and Semipermeable Gloves Compared for Hand Dermatoses

Comfort gloves, made from semipermeable materials could aid condition management for patients with hand dermatoses according to a recent study

Psoriasis Not a Direct Cause of Coronary Obstructive Pulmonary Disease

A study has explored the relationship between psoriasis and COPD to determine whether psoriasis patients are at increased risk for developing COPD.

The Link Between Hyperreactive Platelets and Cardiovascular Disease

Research has determined that hyperreactive platelets, driven by adenosine diphosphate and epinephrine, are significantly associated with cardiovascular diseases

Global Trends Reveal Lifestyle's Role in Shaping Dementia Risk

Research suggests that lifestyle changes, particularly in education and smoking cessation, may be contributing to a decline in dementia incidence in certain regions.

Stress Diminishes Cognitive Reserve's Protective Role in Dementia

Recent research from the Karolinska Institutet in Stockholm has shed light on the complex relationship between cognitive reserve and stress.

Ustekinumab: A Promising Early Treatment for Type 1 Diabetes

Researchers at Cardiff University have identified that Ustekinumab may effectively manage the early stages of Type 1 diabetes in children and adolescents.

Childhood Type 1 Diabetes is Linked to Increased Mental Health Risks

According to recent findings, individuals who develop Type 1 diabetes face a heightened risk of mental health disorders.

Multiple Myeloma Therapy Outcome Predicted Using Simple Blood Test

Study shows that monitoring absolute lymphocyte count after BCMA CAR-T therapy in relapsed or refractory multiple myeloma can predict treatment outcomes.